CLRB Q3'26 Earnings: EPS estimate is (0.56) USD

What happened

Cellectar Biosciences is set to announce its Q3'26 results on October 29 at 8:00 AM ET, which is 12:00 PM UTC. The revenue estimate is 0 USD, and the earnings per share estimate is (0.56) USD.

Confirmed

Global impact / market context

A negative earnings per share estimate means analysts expect a loss rather than a profit, while a zero revenue estimate suggests no expected sales. The report will show whether actual results differ from these expectations.

Confirmed

The article lists past earnings per share surprises, including a shortfall in the prior quarter when the reported loss was worse than the estimate. That history may lead investors to focus on whether the latest result beats or misses the current estimate.

Analyst inference

What to watch

1. Watch the Q3'26 earnings per share report against the (0.56) USD estimate, because a smaller loss than expected would be a positive surprise and a larger loss a negative one. Confirmed
2. Watch reported revenue against the 0 USD estimate, since any actual sales would change the picture of a company analysts currently expect to record no revenue this quarter. Analyst inference
3. Watch whether the company provides any guidance beyond Q3'26 results, since forward-looking comments could shape investor expectations for future quarters and the stock. Proposed

Evidence

• Original source link unavailable